Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) is -86.81% lower on its value in year-to-date trading and has touched a low of $0.48 and a high of $6.18 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The QNRX stock was last observed hovering at around $0.56 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $0.65, the stock is -4.41% and -6.28% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.85 million and changing 14.99% at the moment leaves the stock -6.18% off its SMA200. QNRX registered -83.95% loss for a year compared to 6-month gain of 5.62%. The firm has a 50-day simple moving average (SMA 50) of $0.68726 and a 200-day simple moving average (SMA200) of $0.69267.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.18% loss in the last 1 month and extending the period to 3 months gives it a 21.35%, and is -10.79% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.56% over the week and 18.09% over the month.
Quoin Pharmaceuticals Ltd ADR (QNRX) has around 4 employees, a market worth around $3.27M and $0.00M in sales. Distance from 52-week low is 35.54% and -89.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-160.77%).
The EPS is expected to grow by 78.42% this year
11.0 institutions hold shares in Quoin Pharmaceuticals Ltd ADR (QNRX), with institutional investors hold 6.03% of the company’s shares. The shares outstanding are 5.05M, and float is at 1.12M with Short Float at 8.50%. Institutions hold 5.89% of the Float.
Quoin Pharmaceuticals Ltd ADR (QNRX) Insider Activity
The most recent transaction is an insider purchase by Dunn Gordon, the company’s Chief Financial Officer. SEC filings show that Dunn Gordon bought 20,000 shares of the company’s common stock on Sep 10 ’24 at a price of $0.81 per share for a total of $16200.0. Following the purchase, the insider now owns 28856.0 shares.
Quoin Pharmaceuticals Ltd ADR disclosed in a document filed with the SEC on Sep 09 ’24 that Dunn Gordon (Chief Financial Officer) bought a total of 8,856 shares of the company’s common stock. The trade occurred on Sep 09 ’24 and was made at $0.79 per share for $7005.0. Following the transaction, the insider now directly holds 8856.0 shares of the QNRX stock.
Still, SEC filings show that on Sep 04 ’24, Carter Denise P. (Chief Operating Officer) acquired 31,813 shares at an average price of $0.78 for $24912.0. The insider now directly holds 47,092 shares of Quoin Pharmaceuticals Ltd ADR (QNRX).
